首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

市场调查报告书

商品编码

1619223

胞外体市场规模、份额、成长分析、按产品、按工作流程、按应用、按最终用途、按地区 - 产业预测，2024-2031 年

Exosomes Market Size, Share, Growth Analysis, By Product (Kits & Reagents, Instruments), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End-Use, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年胞外体的全球市场规模估值为2.508亿美元，从2023年的3.2579亿美元成长到2031年的26.4125亿美元，在预测期内（2024-2031）预计复合年增长率为29.9%。

细胞外囊泡（EV），通常称为胞外体，是在各种体液中普遍存在的细胞信使，包括血清、尿液和母乳。它运输蛋白质和遗传物质的能力在诊断和治疗中发挥重要作用，尤其是在癌症发生率上升的情况下。胞外体市场的主要驱动因素包括胞外体分离技术的进步、研究经费的增加以及癌症等疾病发生率的增加，预计到 2023 年癌症将导致近 1000 万人死亡。此次疫情也是创新的催化剂，以外胞外体为基础的 COVID-19 疫苗的开发就是例证。这些囊泡有望带来重要的治疗益处，例如药物传递效率和低毒性，从而在未来几年形成快速增长的疾病检测和创新治疗市场。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

QIAGEN（Germany）
Takara Bio Company（Japan）
Illumina, Inc.（USA）
Thermo Fisher Scientific, Inc.（USA）
Codiak Biosciences（USA）
Exosome Diagnostics（USA）
Evox Therapeutics（UK）
ExCoBio Inc.（South Korea）
Bio-Rad Laboratories Ltd.（USA）
NanoSomix, Inc.（USA）
System Biosciences（SBI）（USA）
Lonza Group（Switzerland）
Miltenyi Biotec（Germany）
Norgen Biotek Corp.（Canada）
AMS Biotechnology（AMSBIO）（UK）
Creative Biolabs（USA）
Capricor Therapeutics（USA）
Aegle Therapeutics（USA）
Anjarium Biosciences（Switzerland）

结论和建议

简介目录

Product Code: SQMIG35H2198

Global Exosomes Market size was valued at USD 250.8 million in 2022 and is poised to grow from USD 325.79 million in 2023 to USD 2641.25 million by 2031, growing at a CAGR of 29.9% during the forecast period (2024-2031).

Extracellular vesicles (EVs), commonly known as exosomes, are ubiquitous cell communication agents found across various bodily fluids such as serum, urine, and breast milk. Their ability to transport proteins and genetic material positions them as crucial players in diagnostics and therapeutics, particularly in the face of rising cancer incidents. Key drivers for the EV market include advancements in exosome separation technologies, increased research funding, and the growing incidence of diseases like cancer-projected to account for nearly 10 million deaths in 2023. The pandemic has also catalyzed innovations, exemplified by the development of exosome-based COVID-19 vaccines. These vesicles promise significant therapeutic benefits, including drug delivery efficiency and low toxicity, thereby shaping a burgeoning market for disease detection and innovative treatments in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Exosomes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Exosomes Market Segmental Analysis

Global Exosomes Market is segmented by product, workflow, application, end-use and region. Based on product, the market is segmented into kits & reagents, instruments and services. Based on workflow, the market is segmented into isolation methods and downstream analysis. Based on application, the market is segmented into cancer, cardiovascular diseases (CVD), neurodegenerative diseases, infectious diseases and others. Based on end-use, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies and hospitals & clinical testing laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Exosomes Market

The growth of the global exosomes market is largely driven by the rising investments in pharmaceutical research and development (R&D) along with life sciences initiatives. Pharmaceutical, biopharmaceutical, and medical device companies allocate substantial resources towards the advancement of innovative drugs and technologies. This investment in R&D is critical for the pharmaceutical industry, which prioritizes the delivery of high-quality, cutting-edge products. Recent trends indicate that major pharmaceutical firms are improving their R&D efficiency through substantial long-term funding and collaborative research ventures, ultimately fueling advancements in exosome technologies and applications across various therapeutic areas.

Restraints in the Global Exosomes Market

The global exosomes market faces significant constraints primarily due to the absence of established standard protocols for exosome development and production. As exosome research remains in its nascent stages, scientists often resort to employing novel techniques and methodologies with little hesitation. This lack of standardization not only presents challenges during the creation of exosomes but also complicates their research, development, and manufacturing processes. While exosomes derived from mesenchymal stem cells (MSCs) are garnering interest for their role as intercellular messengers, there is an urgent need for industry leaders to innovate effective harvesting techniques and develop comprehensive standards for exosome characterization and purification to advance their application in areas like vaccine development, cancer diagnostics, and gene therapy.

Market Trends of the Global Exosomes Market

The Global Exosomes market is experiencing a significant upward trend driven by the increasing recognition of exosomes as a versatile treatment platform for various conditions, notably including COVID-19. Their unique ability to deliver therapeutic cargo while minimizing immune rejection positions exosomes as a promising cell-free therapeutic option for numerous diseases and tissue regeneration applications. The growing interest in exosomal therapy, particularly for respiratory viral infections like SARS-CoV-2, underscores the potential of stem cell-derived exosomes to leverage anti-inflammatory and regenerative properties. This trend indicates a robust future for exosome-based treatments as they gain acceptance in the medical community.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Exosomes Market Size by Product & Service & CAGR (2024-2031)

Market Overview
Kits & Reagents
- Isolation Kits
- Purification Kits
- Detection Kits
Instruments
- Ultracentrifuges
- Flow Cytometers
- Others
Services
- Exosome Isolation Services
- Exosome Characterization Services
- Exosome Profiling Services

Global Exosomes Market Size by Workflow & CAGR (2024-2031)

Market Overview
Isolation Methods
- Ultracentrifugation
- Immunocapture On Beads
- Precipitation
- Filtration
- Others
Downstream Analysis
- Flow Cytometry
- Mass Spectrometry
- Next-Generation Sequencing (NGS)
- Western Blotting
- Others

Global Exosomes Market Size by Application & CAGR (2024-2031)

Market Overview
Cancer
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
Cardiovascular Diseases (CVD)
Neurodegenerative Diseases
Infectious Diseases
Others

Global Exosomes Market Size by End-Use & CAGR (2024-2031)

Market Overview
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Clinical Testing Laboratories

Global Exosomes Market Size & CAGR (2024-2031)

North America (Product & Service, Workflow, Application, End-Use)
- USA
- Canada
Europe (Product & Service, Workflow, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Service, Workflow, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Service, Workflow, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Service, Workflow, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Company (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codiak Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exosome Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evox Therapeutics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ExCoBio Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoSomix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
System Biosciences (SBI) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AMS Biotechnology (AMSBIO) (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biolabs (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Capricor Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aegle Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anjarium Biosciences (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments